Loading viewer...
investor_presentation
Format: PDF investor_presentation
enVVeno Medical develops surgical and non-surgical replacement venous valves to treat Chronic Venous Insufficiency (CVI). The company is conducting the SAVVE U.S. pivotal trial for its VenoValve® and targeting deep venous CVI patients with a total addressable market of 2.5–3.5 million patients in the U.S.
investor_presentation
28 Pages
enVVeno (NVNO) December 2022 Investor Presentation
investor_presentationinvestor_presentation
29 Pages
investor_presentation
26 Pages
American Pacific Mining Corp